CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.

Randomness inside cells can decide whether a cancer returns after chemotherapy or whether an infection survives antibiotics.

It is well known that aging brings an increased likelihood of developing cancer. What is not well understood are the cellular and molecular events that initiate the cancer. Now, researchers at the ...

Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy by harnessing the body's immune system to target ...

To fully understand cancer, researchers must use methods that allow them to fully appreciate heterogeneity within tumors and across the tumor microenvironment. New computational and omics technologies ...

Researchers uncovered a powerful weakness in lung cancer by shutting down a protein that helps tumors survive stress. When this protein, FSP1, was blocked, lung tumors in mice shrank dramatically, ...

Why does cancer sometimes recur even after successful treatment, or why do some bacteria survive despite the use of powerful ...

A large team of researchers led by Wouter Karthaus, head of the Endocrine Therapy Resistance and Molecular Genetics Lab at ...

A newly discovered genetic mutation unique to humans may help explain why we are significantly more vulnerable to cancer than our closest evolutionary relatives. Researchers at the University of ...